270 related articles for article (PubMed ID: 22648554)
1. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).
Howard JH; Thompson JF; Mozzillo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Reintgen DS; Kashani-Sabet M; Karakousis CP; Coventry BJ; Kraybill WG; Smithers BM; Elashoff R; Stern SL; Cochran AJ; Faries MB; Morton DL
Ann Surg Oncol; 2012 Aug; 19(8):2547-55. PubMed ID: 22648554
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
3. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
Morton DL; Thompson JF; Essner R; Elashoff R; Stern SL; Nieweg OE; Roses DF; Karakousis CP; Mozzillo N; Reintgen D; Wang HJ; Glass EC; Cochran AJ
Ann Surg; 1999 Oct; 230(4):453-63; discussion 463-5. PubMed ID: 10522715
[TBL] [Abstract][Full Text] [Related]
4. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
5. Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden.
Spillane AJ; Pasquali S; Haydu LE; Thompson JF
Ann Surg Oncol; 2014 Jan; 21(1):292-9. PubMed ID: 24052314
[TBL] [Abstract][Full Text] [Related]
6. Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Puleo CA; Coventry BJ; Kashani-Sabet M; Smithers BM; Paul E; Kraybill WG; McKinnon JG; Wang HJ; Elashoff R; Faries MB;
N Engl J Med; 2014 Feb; 370(7):599-609. PubMed ID: 24521106
[TBL] [Abstract][Full Text] [Related]
7. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
8. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract][Full Text] [Related]
9. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.
Bartlett EK; Lee AY; Spanheimer PM; Bello DM; Brady MS; Ariyan CE; Coit DG
Br J Surg; 2020 Oct; 107(11):1480-1488. PubMed ID: 32484242
[TBL] [Abstract][Full Text] [Related]
10. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
[TBL] [Abstract][Full Text] [Related]
11. Stage III thick (>4.0 mm) lower extremity melanoma: is timing of lymph node involvement a prognostic factor?
Herman K; Wysocki WM; Skotnicki P; Tabor J; Luczyńska E; Komorowski AL
World J Surg; 2009 Mar; 33(3):469-74. PubMed ID: 19148700
[TBL] [Abstract][Full Text] [Related]
12. Concerns relating to the conduct and statistical analysis of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in patients with melanoma.
Thomas JM
J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):442-6. PubMed ID: 19246272
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant irradiation for axillary metastases from malignant melanoma.
Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
[TBL] [Abstract][Full Text] [Related]
14. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer N; Berking C; Sunderkötter C; Kaatz M; Schulte KW; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Martus P; Garbe C;
Lancet Oncol; 2016 Jun; 17(6):757-767. PubMed ID: 27161539
[TBL] [Abstract][Full Text] [Related]
15. The management of cervical lymph nodes in patients with cutaneous melanoma.
Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
[TBL] [Abstract][Full Text] [Related]
19. Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.
Holtkamp LH; Wang S; Wilmott JS; Madore J; Vilain R; Thompson JF; Nieweg OE; Scolyer RA
Ann Surg Oncol; 2015 Sep; 22(9):2972-7. PubMed ID: 25990968
[TBL] [Abstract][Full Text] [Related]
20. Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.
Nelson DW; Fischer TD; Graff-Baker AN; Dehal A; Stern S; Bilchik AJ; Faries MB
Ann Surg Oncol; 2019 Dec; 26(13):4610-4618. PubMed ID: 31183639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
